Document is current
Any future updates will be listed below
-
Authors
Lan, Nick S. R. https://orcid.org/0000-0002-7222-7314
Hiew, Jonathan https://orcid.org/0000-0002-8109-0778
Ferreira, Ivana https://orcid.org/0000-0002-7309-3960
Ritter, J. Carsten https://orcid.org/0000-0001-8818-9079
Manning, Laurens https://orcid.org/0000-0003-4334-5351
Fegan, P. Gerry https://orcid.org/0000-0001-8100-6209
Dwivedi, Girish https://orcid.org/0000-0003-0717-740X
Hamilton, Emma J. https://orcid.org/0000-0003-1617-6353
-
Funding
Funding for this research was provided by:
Western Australian Future Health Research and Innovation Fund
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 27 September 2024
First Online: 7 November 2024
Data availability
: All relevant data are contained within the manuscript.
: NSRL is supported by a Western Australian Future Health Research and Innovation Fund and an Athelstan Saw Clinician Researcher Training Scholarship from The University of Western Australia and the South Metropolitan Health Service. This activity has been supported by the Western Australian Future Health Research and Innovation Fund (WA Near Miss Awards Emerging Leaders 2022, to EJH).
: NSRL has received research funding from Sanofi as part of a Clinical Fellowship in Endocrinology and Diabetes, education support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, CSL Seqirus, Eli Lilly, Novartis and Pfizer, and speaker honoraria from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Menarini, Novartis and Sanofi, and has participated in advisory boards for Eli Lilly. GD has delivered paid lectures for AstraZeneca, Pfizer and Amgen, and provides consultancy services for and has equity interest in Artrya Ltd. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.
: All authors were involved in the conception, design and conduct of the study and interpretation of the results. NSRL was involved in the statistical analysis and wrote the first draft of the manuscript. All authors edited, reviewed and approved the final version of the manuscript. NSRL is the guarantor of this work, and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
